Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients

Share:

Listens: 0

GRACEcast Head and Neck Cancer Video NEW

Science


6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.